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Given that unnatural sugar expression is metabolically achieved, the kinetics and disposition of
incorporation can lend insight into the temporal and localization preferences of sialylation across the cell
surface. However, common detection schemes lack the ability to detail the molecular diversity and
distribution of target moieties. Here we employed a mass spectrometric approach to trace the
placement of azido sialic acids on membrane glycoconjugates, which revealed substantial variations in
incorporation efficiencies between N-/O-glycans, glycosites, and glycosphingolipids. To further explore
the propensity for sialylation, we subsequently mapped the native glycome of model epithelial cell
surfaces and illustrate that while glycosylation sites span broadly across the extracellular region, a higher
number of heterogeneous glycoforms occur on sialylated sites closest to the transmembrane domain.
Beyond imaging techniques, this integrative approach provides unprecedented details about the
frequency and structure-specific distribution of cell surface sialylation, a critical feature that regulates
cellular interactions and homeostatic pathways.Introduction
Sialic acids comprise a nine-carbon, a-keto family of mono-
saccharides that exist as diverse forms resulting from functional
group variations and differences in connecting linkages. The
prime location of sialic acids at the ends of membrane and
secreted glycoproteins contributes in large part to their exploi-
tation by viruses, bacteria, and toxins that recognize sialylated
ligands with high specicity.1–4 Contributing to the pathogen-
esis of gastrointestinal and systemic infections, sialic acids can
be taken up and utilized by bacteria as an energy source or
incorporated into capsular or lipopolysaccharide components,
protecting them from host immune recognition. Similarly,
tumor cells have been shown to express aberrantly high levels of
sialylation, which permits immune escape by blocking
complement activation, cytotoxic granule release, and physical
interaction.5 Following this complexity, ongoing studies activelyifornia, Davis, CA 95616, USA
ness Medical Center, Harvard Medical
ark4@bidmc.harvard.edu
dicine, Khon Kaen University, Khon Kaen
Biomedical Sciences, Fudan University,
f California, Davis School of Medicine,
tion (ESI) available. See DOI:
hemistry 2018seek efficient synthetic schemes in complement with detailed
structural analysis of sialylated glycoconjugates toward
improved understanding of their functions.
Metabolic labeling has become the foremost strategy to
install and selectively scan sialic acids on cell surfaces.6–9 This
approach utilizes the cell's endogenous biosynthetic machinery
to convert and activate exogenously administered variants of
N-acetylmannosamine (ManNAc) which then get incorporated
into native glycoconjugates as the corresponding N-acetylneur-
aminic acid (Neu5Ac). However, due to the non-templated
fashion of glycan assembly, a vast complexity of structures is
generated that are difficult to sequence compared to other
macromolecules such as proteins and DNA. Consequently,
information about the levels, efficiency, and products of
incorporation remain unresolved, which limits its use for
probing functional relevance. Structural characterization is
particularly valuable given that certain sialylated moieties, such
as sialyl Lewis X, sialyl Tn antigen, and sialylated poly-N-ace-
tyllactosamine (poly-LacNAc), may have specialized func-
tions.10–14 Although uorescent tags are commonly used for
visualizing labeled cells,15–17 this technique cannot locate the
residue-specic sites of glycosylation that have converted to
unnatural forms and may actually result in false positive
measurements.18 Moreover, under the premise that sialic acids
reside in high density on the surface of many types of cancer
cells, identifying the sites where sialylation occurs on a glyco-
protein is a central goal toward regulating their molecular
interactions with therapeutics. Therefore, global mapping ofChem. Sci., 2018, 9, 6271–6285 | 6271
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View Article Onlinethe occurrence of sialylated sites and glycans, principally on
specied domains of membrane proteins, would help elucidate
how sialylated glycans amplify or demote biological activity.
In parallel with metabolic labeling, advanced analytical tools
are emerging to enable full characterization of unnaturally
glycosylated proteins using isotopic labeling or chemical liga-
tion followed by affinity purication.19–21 Here, we present
a platform to comprehensively survey the structures of modied
glycans on the cell membrane in addition to their associated
glycoproteins and glycosphingolipids with minimal sample
manipulation. In our approach, the protein-, site-, glycan-, and
lipid-specic locations of azido sialic acids were probed by
using the monosaccharide as a mass label, removing the need
for additional conjugation and capture steps. The wide range of
observed incorporation rates of the unnatural sugar subse-
quently prompted in-depth identication of native cell surface
glycoproteins. This detail was used to map the occurrence of
sialic acids on the extracellular domain and explore the factors
that dictate or accompany sialylation.Results
Locating unnatural sialic acids on cell membrane glycans
To comprehensively survey cell surface sialic acid expression,
azide functional groups (azido N-acetylneuraminic acid, Sia-
NAz) were metabolically installed across sialo-glycoconjugates
for utility as unique mass reporters (Fig. 1). Within the mixture
of released and puried N- and O-glycans sourced from various
epithelial cell lines, SiaNAzylated glycans were distinguished
from other structures by diagnostic ions originating from the
unnatural monosaccharide. The SiaNAz residue has a signature
mass of 332.10 Da, distinct from the mass of other mono-
saccharides. Using CID-MS/MS, fragment ions m/z 315.09 [Sia-
NAz  H2O + H]+ and m/z 333.10 [SiaNAz + H]+ unambiguously
indicated the presence of the unnatural sialic acid in the
selected glycan precursor. The acquired mass spectra of SiaNAz-
incorporated structures that are representative of typical
N-glycan classes and mucin type O-glycans are shown in
Fig. S1.† In addition to compounds that incorporated SiaNAz
residues on all possible sites of sialylation (Fig. 2A, top panel),
we observed evidence of singly or partially incorporated struc-
tures (Fig. 2A, bottom panel). During the chemical release of
O-glycans, which is performed in the presence of a reducing
agent, we observed the conversion of the azide to an amine
(Fig. S2†). Thus, glycans containing the reduced SiaNAz residue
(SiaNAm, 306.11 Da) were also included as products of meta-
bolic labeling. Amino sialic acids were otherwise absent in
untreated controls. This analysis provided retention time
stamps and chromatographic proles of individual SiaNAz-
incorporated N- and O-glycans, enabling consideration for
quantitative measures.Quantitation of unnatural sialic acid incorporation
To accurately enumerate the efficiency and extent of incorpo-
ration across all sialylated species, addition of azido N-ace-
tylmannosamine (ManNAz), the metabolic precursor of SiaNAz,6272 | Chem. Sci., 2018, 9, 6271–6285was optimized by dose- and time-response measurements
(Fig. S3†). It is evident that every cell bears its own N-glycan
signature that is uniquely decorated by features such as fuco-
sylation, sialylation, and mannosylation.22–26 Accordingly,
among the epithelial cells we examined, the extent of SiaNAz
incorporation was related to the tissue of origin (Fig. S4†). Of
note, however, the starting amounts of sialylation did not
heavily inuence the incorporation efficiency. Q-RT-PCR
measurements further showed that expression levels of sialyl-
transferases were not the primary basis for determining the
incorporation efficiency (Fig. S5†). PNT2, derived from non-
tumorigenic prostate epithelial cells, showed the highest level of
incorporation. Approximately 72% of its sialylated N-glycans
possessed at least one SiaNAz residue (Fig. 2B). Collectively, Sia-
NAzylated structures comprised 84% of the summed abundances
of all its sialylated N-glycans. Differentiated enterocytic Caco-2
cells required the highest amount of ManNAz (100 mM) but
showed the lowest level of incorporation. On average, of the 252
sialylated N-glycan structures identied on Caco-2, 105 (42%)
possessed one or more SiaNAz residues. Based on abundances,
SiaNAz-containing N-glycans accounted for 29% of the total cell
surface sialylation. The reproducibility of incorporation was vali-
dated by replicate experiments (Fig. S6†). In subsequent analyses,
therefore, we centered on PNT2 and Caco-2 glycosylation.
For deeper comparison of the N-glycome between treated and
untreated cells, we evaluated the incorporation efficiencies of
individual sialylated structures with relative abundances >0.5%.
In the presence of ManNAz, the identity of cell surface glycans
generally remained similar to those native to the control (Fig. 3C),
suggesting that the glycan processing sialyltransferases permit
the addition of modied sialic acids during synthesis of nascent
glycans. Signicantly, our analysis indicated that incorporation
varies with structure. Based on eqn (1) (Fig. 1), incorporation
levels perN-glycan ranged from 17% to 55% inCaco-2 and 76% to
97% in PNT2. Although the introduction of a monosaccharide
variant to cells did not cause major deviations in glycan biosyn-
thesis, certain azido glycans were generated at higher levels than
others. SiaNAzylated structures with the highest abundances
corresponded to the most abundant non-SiaNAzylated struc-
tures (Hex5HexNAc5Fuc1Sia1/Hex5HexNAc5Fuc1SiaNAz1, Caco-2;
Hex5HexNAc4Fuc1Sia1/Hex5HexNAc4Fuc1SiaNAz1, PNT2). However,
the abundances of structures with the highest incorporation
rate were low or only moderate (Hex5HexNAc4Fuc1Sia2, Caco-2;
Hex6HexNAc5Fuc2Sia2 and Hex5HexNAc5Fuc1Sia2, PNT2). The
efficiency of incorporation may be dictated by features of the
originating proteins.
Incorporation of SiaNAz onto O-linked glycans was in turn
monitored by alkaline beta-elimination immediately following
de-N-glycosylation. Interestingly, Caco-2 showed a low N-glycan
incorporation rate overall but expressed SiaNAz-O-glycans
with high efficiency. Of all sialylated O-glycan structures on
Caco-2, about 55% incorporated SiaNAz, comprising 74% of
the total sialylated O-glycan abundance (Fig. 2D). In contrast,
PNT2 displayed a lower percentage of incorporated structures in
itsO- than its N-glycome. According to abundance, SiaNAzylated
O-glycans accounted for 56% of all sialylated O-glycans. Unlike
Caco-2, a major proportion of O-glycans exemplied natively onThis journal is © The Royal Society of Chemistry 2018
Fig. 1 Isolation, identification, and quantitation of glycoconjugates associated with the plasma membrane. Each cell is uniquely decorated by
signature glycoproteins and glycolipids that are of various compositions and lengths. Based on structural features, isolation techniques were
optimized for free and intact glycoconjugate analysis. Upon identification, unnatural sialic acid incorporation was calculated according to
abundances (I, intensity).
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View Article OnlinePNT2 were sialylated (84% by abundance) (Fig. S7†). In partic-
ular, a disialylated core 2 glycan (Hex2HexNAc2Sia2) was the
predominant species, indicative of its association with mucin-
type glycoproteins. Correspondingly, compounds that incorpo-
rated the highest amount of SiaNAz on PNT2 consisted of sialyl
core 2 (Hex2HexNAc2Sia1SiaNAz1 and Hex2HexNAc2SiaNAz2)
and core 1 (Hex2HexNAc2SiaNAz1) structures. In this regard,This journal is © The Royal Society of Chemistry 2018similar to N-glycan analysis, the most abundant SiaNAzylated
O-glycans paralleled the most abundant sialylated O-glycans.
However, percent incorporation differed by individual O-glycan
structure, regardless of the abundance order (Table S1†). The
variability in incorporation rates across glycan structures
prompted investigation of where specic glycans are attached
on membrane proteins.Chem. Sci., 2018, 9, 6271–6285 | 6273
Fig. 2 Profiling SiaNAzylated N- and O-glycans of the cell surface. (A) MS/MS spectra of N-glycan structures that have doubly (top panel) or
singly (bottom panel) incorporated SiaNAz. Fragment ions m/z 292.10 (dehydrogenated m/z 274.08) and m/z 333.11 (dehydrogenated m/z
315.08) indicate the presence of Sia and SiaNAz, respectively, in the selected glycan precursor. (B) Net percent incorporation of SiaNAz onto
N-glycans. (C) Relative abundances of sialylated N-glycans on ManNAz-treated Caco-2 and PNT2 (threshold >0.5%). Bar graphs are arranged by
order of percent incorporation, as indicated in the inset (high to low, left to right). (D) Net percent incorporation of SiaNAz onto O-glycans.
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View Article OnlineIntra-protein incorporation differences
While free glycan analysis yields information about the diversity
and composition of the glycan structures present in a sample,
the parent protein and originating site of attachment are le
unknown. Therefore, to compare between SiaNAzylated sites,
we performed the study in the absence of PNGase F, preserving
the site of glycan attachment, digested the proteins with trypsin,
and searched specically for glycopeptides with the SiaNAz
mass label by C18-LC-MS/MS. Among the most abundant
glycoproteins expressed on the Caco-2 cell membrane, cad-
herin-17 (CDH17) was distinctive in that all occupied sites were
sialylated: N250, N419, N546, N587, and N722. Each site of
glycosylation belonged to a distinctive extracellular cadherin
domain (cadherin 3–7) (Fig. 3A) and uniquely expressed varying
numbers of glycoforms (Fig. 3B). To calculate site-specic6274 | Chem. Sci., 2018, 9, 6271–6285incorporation, we employed a label-free approach using the
area under the peak (Fig. 3C) and normalized to the species with
the highest abundance, according to eqn (1) (Fig. 1 and S8†).
Among occupied sites, N587 was highest expressed and
encompassed the highest diversity of sialylated structures (Fig. 3B).
Within this site, six abundant singly SiaNAzylated glycans were
identied: Hex5HexNAc4Fuc2SiaNAz1, Hex5HexNAc4Fuc1SiaNAz1,
Hex4HexNAc5Fuc1SiaNAz1, Hex6HexNAc5Fuc1SiaNAz1,
Hex5HexNAc5Fuc1SiaNAz1, and Hex5HexNAc5Fuc2SiaNAz1.
Similar to glycomic analysis, the most abundant glycoform in
untreated and treated cells was modied with a bisecting
N-acetylglucosamine (GlcNAc) structure, Hex5HexNAc5Fuc1Sia1
and Hex5HexNAc5Fuc1SiaNAz1, respectively (Fig. 3B and D). A
range of incorporation levels was observed for each glycoform at
N587. However, the extent of SiaNAz incorporation at each siteThis journal is © The Royal Society of Chemistry 2018
Fig. 3 Quantitation of site-specific incorporation of SiaNAz. (A) Features of the glycosylatedmembrane protein, cadherin-17, shown in sequence
view from position 1 to 832. (B) Site-specific glycan structures observed on cadherin-17. Non-sialylated glycoforms are drawn in grayscale. Pie
charts show the intensity of each site relative to the most abundant site, N587 (denoted as 100%). (C) Chromatograms of the most abundant
sialylated and SiaNAzylated glycoforms expressed on cadherin-17 at N587. (D) Site-specific abundances of sialylated glycoforms identified on
cadherin-17 at N587. Pie charts indicate the contribution of each glycoform relative to the most abundant glycoform observed at each site per
group. Colors differentiate between untreated and treated groups (+/ManNAz) in addition to unmodified andmodified sialic acid (+/ SiaNAz).
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View Article Onlinedid not correlate with the order of abundance of glycans
observed at a given site. For example, we observed only 10%
incorporation on Hex5HexNAc5Fuc1SiaNAz1, despite its high
abundance. In particular, the glycoform bearing Hex5HexNAc4-
Fuc1SiaNAz1 exhibited the highest level of incorporation (86%)
while the glycoform bearing Hex4HexNAc5Fuc1SiaNAz1 showed
the lowest (3%). Among all glycosylated sites of CDH17, the
maximum level of incorporation was observed in the glycoform
containing Hex5HexNAc4Fuc1SiaNAz1 on a remote site, N722. Of
note, N722 is the last occupied glycosylation site of CDH17
nearest to its transmembrane domain (Fig. 3A). According to
site-specic analysis, different sites on the same protein dis-
played a range of glycan compositions and each glycoform
incorporated SiaNAz with varying efficiencies. As observed with
glycan analysis, incorporation efficiencies within and between
sites were not contingent on abundance order.Site-specic map of membrane glycoproteins
Upon observing differential incorporation of SiaNAz residues
on membrane glycans and between protein sites, we proposedThis journal is © The Royal Society of Chemistry 2018that the general propensity for sialylation across sites may be
inuenced by the composition of surrounding amino acids and
the chemical environment. Following the growing need to
systematically dene all glycosylated sites, we used a large-scale
approach, which involves membrane extraction, protease diges-
tion, glycopeptide enrichment, and informative fragmentation.
Due to the low ionization efficiency of glycopeptides and
suppression of ions during MS analysis, we performed high
recovery pre-enrichment using iSPE®-HILIC, a newly designed
hydroxyethyl amide-based matrix, which substantially out-
performed other methods of enrichment (Fig. S9†). Using this
technique, we observed multifold increases in the number and
abundance of glycopeptides identied and more than 90%
enrichment of glycopeptides over non-glycosylated peptides in
the cell membrane fraction (Fig. S10†). In addition, iSPE®-HILIC
resolved glycosites previously unidentied using conventional
zwitterionic (ZIC)-HILIC.
Oen both glycan and protein information cannot be ob-
tained in a single experiment because different energies are
required to fragment the oligosaccharide and the peptide
backbone. Here, we employed stepped collision energyChem. Sci., 2018, 9, 6271–6285 | 6275
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View Article Onlinegenerating ions by a combination of low, medium, and high
energies. In this way, multiple component information arising
from peptide, glycan, and glycopeptide fragmentation was
simultaneously acquired to increase sequence coverage, iden-
tify saccharide structural motifs, and localize sites, respectively
(Fig. S11†). To aid glycopeptide identications, the composi-
tions we elucidated with global glycan release were used to
develop a focused library and bracket the search. Data were
ltered strictly by protein p-value (|log prob| >2), delta mod
(>10), and byonic score (>200) to eliminate false positives.
Independent replicate analyses validated the identications
(Fig. S12†). As a result, we successfully characterized spectraFig. 4 Characteristics of the total cell surface glycoproteome of Caco-2
glycoforms identified on Caco-2 and PNT2. (B) Classification of membran
is extended into the extracellular domain. (C) Comparison of the number
glycoproteins.
6276 | Chem. Sci., 2018, 9, 6271–6285matched to 444 N-glycan sites on 165 Caco-2 cell surface
glycoproteins, giving rise to 2553 nonredundant glycoforms
(Fig. 4A, and Tables S2 and S3†). Although uncommon, 47
additional, distinct glycoforms from short tryptic peptides with
four or less amino acids were identied but excluded from
subsequent analysis due to the ambiguity in assigning their
originating protein. About 62% of all glycoproteins were clas-
sied as single-pass transmembrane proteins, of which 52%
expose the N-terminus to the extracellular domain while 10%
present the C-terminus (Fig. 4B). Additionally, 20% multi-pass
transmembrane proteins contained polytopic loops with more
than one region of the protein extending into and out of theand PNT2. (A) The number of membrane-associated proteins, sites, and
e-associated glycoproteins by the specific region(s) of the protein that
of occupied glycosylated sites found on sialylated versus non-sialylated
This journal is © The Royal Society of Chemistry 2018
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View Article Onlineextracellular region. The remaining 18% of identied glyco-
proteins were lipid-linked, peripheral, or secretory. On PNT2,
186 N-glycosites and 553 nonredundant glycoforms were iden-
tied on 112 cell surface glycoproteins in total (Tables S4 and
S5†). The types of glycosylated transmembrane proteins were
similar to those on Caco-2, where the majority of extracellular
regions were N-terminal ends of proteins.
With knowledge of the compositions of glycans associated at
each site, we effectively distinguished sialylated glycoproteins
from those lacking sialic acid residues. Based broadly on the
respective polypeptide backbone of proteins, the presence of
sialylation did not directly correlate with the properties of the
naked protein alone, such as length, net charge, grand average of
hydrophobicity (GRAND), or aliphatic index (Fig. S13†). With
respect tomolecular function, the highest percentage of proteins
was classied as having binding, catalytic, or receptor activitiesFig. 5 Distinctions between sialylated and non-sialylated sites of glyco
occupied sites of glycosylation specific to the extracellular domain. The
representing the transmembrane domain and the protein terminus, resp
pink markers, respectively. (B) Graphical representation of the number of
the extracellular domain.
This journal is © The Royal Society of Chemistry 2018regardless of the occurrence of sialylation. As a result of struc-
tural constraints, it has been predicted that processed complex
type N-glycans occur at sites distant from disulde bonds.27 On
average, non-sialylated proteins possessed slightly more disul-
de bonds than sialylated proteins. However, the number of
disulde bonds alone did not distinguish sialylated proteins
from non-sialylated proteins. Notably, while the chemical and
molecular features of their underlying proteins were similar, we
observed that sialylated glycoproteins had higher numbers of
occupied N-glycan sites than their non-sialylated counterparts.
Approximately 61% of sialylated Caco-2 proteins were glycosy-
lated atmore than one site whereas 42% of non-sialylated Caco-2
proteins possessed multiple occupied sites of glycosylation
(Fig. 4C). Similarly, more than one glycosylation site was occu-
pied in about 41% of sialylated PNT2 proteins versus 26% of non-
sialylated proteins. Unique to Caco-2, sialylated and non-sylation on the extracellular domain. (A) Graphical representation of
relative position of glycosylation was given a value between 0 and 1,
ectively. Sialylated and non-sialylated sites are indicated as green and
glycoforms with respect to the position of their glycosylation site along
Chem. Sci., 2018, 9, 6271–6285 | 6277
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View Article Onlinesialylated proteins were differentiated (P < 0.05, Student's t-test)
based solely on the number of occupied sites.
Sialylation dynamics of extracellular domains
Following the observation that glycosylation is limited to the
extracellular space, the sequence of single pass transmembrane
proteins was assigned a value ranging from 0 to 1, representing
the region from the end of the transmembrane helix to the
protein terminus (Fig. 5A). From this normalized pictorial
representation, we observed that glycosites span broadly across
the extracellular region. When we surveyed the lateral arrange-
ment of sites with respect to the presence or absence of sialyla-
tion, sites with sialylated glycans were dispersed broadly as
opposed to being polarized on any one region of the protein. By
prediction modeling, the majority of glycosylated sites were
located on coiled regions of the protein (Fig. S14†). We further
screened each glycosylated site based on the occurrence ofFig. 6 Glycosphingolipid (GSL) identification, quantitation, and classi
structures on Caco-2 and PNT2 by order of abundance (Tables S6 and S7†
(GlcNAc) or N-acetylgalactosamine (GalNAc) can be attached. (B) Com
group and the ceramide tail.
6278 | Chem. Sci., 2018, 9, 6271–6285sialylation. Compared to non-sialylated sites, sialylated sites
tended to exhibit greater heterogeneity. About 82% of sialylated
Caco-2 and 72% of sialylated PNT2 sites showed more than one
glycoform on each site (Fig. 5B). The maximum number of gly-
coforms observed on any one site was as high as 51 on sialylated
Caco-2 and 25 on sialylated PNT2 membrane proteins. In
comparison, at non-sialylated Caco-2 and PNT2 membrane sites,
a maximum of eight and six glycoforms were observed, respec-
tively. In general, a higher proportion of glycoproteins were
identied that possessed the tri-amino acid motif Asn-Xaa-Thr
than Asn-Xaa-Ser (about 1.3 : 1, where Xaa is any amino acid
except Pro) (Fig. S15†). When considering residue frequencies at
surrounding positions, neither Xaa within the N-glycosylation
motif sequence nor residues 9 from the consensus motif
distinguished sialylated sites from non-sialylated sites. Repeated
leucine residues were more frequently located on the N-terminal
side of glycosylated sites.fication. (A) Glycosphingolipid wheel depicting elucidated sialylated
). Open squares represent positions where eitherN-acetylglucosamine
parison of sialylated GSLs (sGSLs) based separately on the polar head
This journal is © The Royal Society of Chemistry 2018
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View Article OnlineProvided that sialylated sites are dispersed throughout the
extracellular domain, we assessed whether the abundances of
glycoforms were spatially related. Strikingly, for single pass
transmembrane proteins, sites bearing the most number of
glycoforms were found nearer to the transmembrane domain
(Fig. 5B). Sites that were more than 1700 residues away from the
transmembrane domain possessed less than ten glycoforms.
From this analysis, we observed that the number of distinct
glycoforms produced per site was inuenced by the location of
the extracellular glycosylation site relative to the trans-
membrane domain as well as the presence of sialylation. The
same trend existed on high and low abundance glycoproteins
and was independent of protein family. Graphical representa-
tions of glycoforms expressed along the extracellular domain on
key membrane proteins are depicted in Fig. S16.†Proling sialylated glycosphingolipid diversity
Sialylation is a major component of glycosphingolipids (GSLs)
interspersed across the cell membrane. These distinctive
structures are composed of a polar head group (glycan), pre-
sented on the outer face of the membrane, and a hydrophobic
tail (ceramide), which inserts into the phospholipid bilayer. The
head group is assembled by a subset of specic glycosyl-
transferases and contains multiple potential sites of sialylation
via glycosidic linkages to itself and/or galactose (terminal or
sandwiched). We isolated intact GSLs from Caco-2 and PNT2
cell membranes to determine the extent of SiaNAz incorpora-
tion at the lipid level as compared to the observed rates at theFig. 7 Quantitation of SiaNAz incorporation onto glycosphingolipids. (A)
graphs are arranged by order of incorporation (high to low, left to right). R
incorporation of SiaNAz onto GSLs according to the number of compou
This journal is © The Royal Society of Chemistry 2018N-/O-glycan and site levels. All identications were veried by
MS/MS (Fig. S17 and S18†). Untreated PNT2 exhibited high
amounts of mono- and di-sialylated GSLs (Fig. 6A and
Table S6†). Strikingly, unlike the patterns of membrane protein
glycosylation, fucosylated GSLs were not observed. The most
common head group was composed of Hex2HexNAc1Sia1 (GM2)
while the most abundant ceramide tail was 42 carbons in length
(Fig. 6B). The ceramide tail of all PNT2 GSLs was unsaturated
and di-hydroxylated. Most of these species (80%) possessed one
degree of unsaturation. In contrast, with a total of 53 unique
sialylated GSL compositions, Caco-2 showed higher diversity
than PNT2 in the types of GSLs embedded in the membrane
(Fig. 6B and Table S7†). With regard to glycosylation, only
monosialylated GSLs were observed on Caco-2. Comprising
78% of all glycosylated head groups, the most abundant sugar
moiety was composed of the GM1 structure Hex3HexNAc3Sia1.
The number of carbon atoms in the hydrophobic tail of any
given GSL on Caco-2 varied from 32 to 44. Among the most
abundant GSLs, nearly 40% possessed ceramides of 42-carbon
units and 33% possessed ceramides of 34-carbon units in
length. Intriguingly, hydroxylation was a key feature of all Caco-
2 GSLs. Approximately 40% were mono-hydroxylated, 55% were
tri-hydroxylated, and 0.1% possessed four hydroxyl groups.
Moreover, the bulk of the ceramide tails were unsaturated
(74%). Of these, 53% were mono-unsaturated and 21% were di-
unsaturated. Di-unsaturation occurred more frequently in
ceramides with 42 or more carbon units.
Aer ManNAz treatment, we observed complete conversion
of sGSLs (sialylated GSLs or gangliosides) into SiaNAzylatedVariations in percent incorporation of SiaNAz onto individual sGSLs. Bar
ank refers to GSLs by order of abundance in untreated controls. (B) Net
nds and relative abundance.
Chem. Sci., 2018, 9, 6271–6285 | 6279
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View Article OnlineGSLs on PNT2. Incorporation was highly efficient, where all
identied sGSLs possessed one or more SiaNAz residues. The
extent of incorporation varied with individual structure. In
particular, the highest level of incorporation (92%) was
observed in a GD1-based structure, Hex3HexNAc1NeuAc2/d34:1
(Fig. 7A), whereas a GM1-based structure, Hex3HexNAc1NeuAc1/
d44:2, showed the lowest level of incorporation (42%). In all
disialylated GSLs, we observed both singly and doubly incor-
porated structures. Similar to what was observed in protein
glycosylation, the most abundant GSLs tended to express higher
abundances of SiaNAz. In total, SiaNAzylated species accounted
for 75% of the abundances of sGSLs (Fig. 7B). In Caco-2, 30 of
the 53 (57%) sGSL compositions incorporated SiaNAz (Fig. 7B).
Based on the summed abundances, an average incorporation
rate of 8% was observed across all SiaNAzylated species aer 72
h. The highest abundant SiaNAzylated GSL compositions were
likewise the highest abundant non-SiaNAzylated GSL compo-
sitions (Fig. 7A).
Discussion
Sialylation occurs through the coordinated action of enzymes
that transfer free sialic acids onto the terminal position of
nascent glycans. The heterogeneity of potentially modied
structures is vast, derived from differences in linkage positions,
connectivity, and multimerity. An important aspect of our
initial global analysis approach was porous graphitized carbon
(PGC)-LC to separate the assortment of released N- and
O-glycans, which encompasses sialylated as well as non-sialy-
lated structures, according to parameters such as size, polarity,
and linkage. We demonstrate that SiaNAzylated species are
uniquely separated and use their retention differences as time
stamps for ease of subsequent identication and quantitation.
Furthermore, the application of a microuidic nanoow chip-
based system permitted minimal injection volumes (mL),
enabling avenues for high throughput screening.
The overall efficiency of azido sialic acid incorporation
differed by cell origin and glycan structure, predictably under
the control of cell-specic factors such as glycosyl enzyme
activity and monosaccharide metabolism. However, further
analyses of protein structure and dynamics are needed to
understand the causes underlying the notable differences in
incorporation efficiencies between N- and O-glycans in addition
to the differences observed between protein glycosylation sites.
For example, turnover kinetics and residue accessibility could
substantially affect the rate of monosaccharide incorporation.
In particular, incorporation of metabolized sugars onto mucin-
type glycoproteins, which are densely packed with repeating
units of O-glycans, may require a different time scale than is
necessary for glycoproteins with less density. Exogenous carbon
sources have indeed been shown to affect mucin biosyn-
thesis.28,29 Relatedly, disparities in the absolute amounts of N-
and O-glycans present on cell surfaces may account for differ-
ences in incorporation. Future studies involve distinguishing
sialyl linkages and introducing other unnatural modications
while quantifying incorporation rates. At large, it is important
for metabolic labeling experiments to control cell culture6280 | Chem. Sci., 2018, 9, 6271–6285parameters, which have been shown to meaningfully affect
glycan expression.30 Enhancing the understanding of single cell
metabolism will provide additional insight into maximizing cell
surface sugar incorporation.
We and others have shown that the parent protein plays
a pivotal role in dening the biological signicance of its gly-
covariants such that its function cannot be recapitulated by the
glycan(s) alone.31–33 Hence, it is important to regard the glycan
as a component of a specic protein. Based on a full-length
comparison between sialylated and non-sialylated proteins,
amino acid sequence composition alone did not play a signi-
cant role in determining the predisposition to sialylation.
Similar to the full-length protein analysis, features of the
surrounding amino acids (local features), including hydropathy
and amino acid residue frequency, failed to distinguish sialy-
lated sites from non-sialylated sites. Laterally along the extra-
cellular domain, occupied glycosylated sites on membrane-
spanning proteins were broadly spaced as opposed to being
polarized on the terminus. While the folded protein confor-
mation may shape where glycosylation occurs on a protein,
many structures remain unsolved. In addition, available crystal
structures oen exclude glycans and thus may not reect the
actual fold. In fact, comparative studies have shown that the
conformation of a glycoprotein is signicantly altered once
glycosylation is removed.34,35 Bioinformatic tools predict that
most of the glycosylation sites we elucidated in this study occur
on coiled congurations of the protein. Three-dimensional
structural characterization of glycoproteins in their native
forms are needed to preserve the actual folded state and depict
the spatial arrangement of sialic acids on the cell membrane
with respect to nearby molecules. Site-specic maps obtained
from our analysis provide details to assist in correlating sites of
sialylation with the protein structure and conserved functional
motifs.
Another interesting nding was garnered upon determining
the heterogeneity of glycoforms associated with each site, which
provided a more complete representation of native glycopro-
teins. Notably, sialylated sites possessed more glycoforms than
their non-sialylated counterparts. Moreover, sites with greater
heterogeneity were generally located closer to the trans-
membrane domain than to the protein terminus. While such
site-specicity was not observed in all membrane glycoproteins,
it was particularly prominent in those with an unusually high
number of glycoforms (>10). Based on this intriguing trend, the
glycosylation status of the transitional region between a glyco-
protein's extracellular and transmembrane domains may
contain information regarding its three-dimensional structure.
Glycansmature aer being transferred to their parent protein in
the ER and Golgi. For initiation, the site of glycosylation must
be present in the luminal side of the ER. Oligosaccharyl-
transferase (OST) then recognizes the consensus sequence and
is responsible for the en bloc transfer of a glycan precursor onto
the polypeptide substructure of the acceptor. It is known that
the transmembrane domain of proteins lacks glycosylation as
the region is inaccessible to OST. Given the nature of the
biosynthetic pathway, glycosylated sites nearest to the trans-
membrane domain may be preferred sites for processingThis journal is © The Royal Society of Chemistry 2018
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View Article Onlineenzymes as they are exposed or energetically favorable for
recognition. Although structural aspects in combination with
enzymatic activity may play a role in promoting a site-specic
increase in glycoforms, the implications of the generated
diversity remain unclear.
Several caveats remain with the methods described here.
Indeed, we have elucidated various new sites and glycoforms on
cells but the identications are not exhaustive. Additional iden-
tications may be obtained, for example, by increasing yields in
membrane protein extraction and by utilizing different cocktails
of specic and non-specic proteases. To enable sufficient
identications without enrichment strategies, enhanced selec-
tion of glycopeptides during the LC-MS/MS experiment and data-
independent tools need to be improved. The current study
affords a detailed view of cell surface glycoproteins. A focused
study of the glycosylation patterns that occur on intracellular
high molecular weight transmembrane proteins is merited.
Apart from our efforts to characterize glycoproteins, we also
tracked the incorporation of SiaNAz onto glycosphingolipids. Due
to their amphipathic nature, their isolation and analysis have
posed a signicant challenge. We provide a comprehensive view
of the types of sGSLs that exist on cells and therefore new insight
into the total sialo-glycome of the cell surface. Glycosphingolipids
participate in adhesion of adjoining cells via the carbohydrate
moieties present on the outer layer of the plasma membrane.36,37
We identied the relevant surface molecules on model intestinal
and prostate epithelial cells and demonstrate that incorporation
of exogenous sialic acids can be exceptionally efficient. These
results promote future studies harnessing the participating sia-
lyltransferases. The localization of sGSLs along the membrane is
difficult to dene as they are not homogenously distributed.38 In
fact, these molecules are predicted to be the main occupants of
specialized regions named lipid ras, which are dynamic in size
and composition depending on the stimuli imposed on the
cell.39,40 The clustering of glycans in these microdomains may
augment opportunities for recognition by nearby biomolecules.
Sialylated GSLs not only effectively mediate cell adhesion but
also activate cell signaling pathways via the ceramide portions.41
The GSL tail has two components, the sphingoid base and the
fatty acid, linked together by an amide bond. Interestingly, the
number of hydroxyl groups is variable in response to cell
conditions and occurs at markedly higher frequencies in
intestinal cells. Indeed, we observed GSLs with >2 hydroxyl
group modications on Caco-2 which were absent on PNT2.
Furthermore, we observed rare structures with ceramide tails
that seemingly possess an odd number of carbon atoms. It is
postulated that these structures include odd-numbered fatty
acids, some of which may have branched chains.42 Ceramides
can thus be distinguished by the carbon length, hydroxyl group
modications, and the degree of unsaturation. The degree of
unsaturation inuences the ability of the tail to pack into the
membrane,43 conferring rigidity, and may also govern the rates
of glycolipid recycling or shedding from the membrane.44
Analyses are ongoing to probe the biological signicance of the
mixture of sGSLs in these contexts.
Analytical advancements, besides characterizing manufac-
tured drug candidates, have the potential to guide the design ofThis journal is © The Royal Society of Chemistry 2018therapeutics with coordinated binding to specied regions of
proteins. Hypersialylation, in particular, is a prevalent feature of
disease progression, reported in cases of cancer, diabetes, and
rheumatoid arthritis.45–48 Moreover, the level of sialic acid
expression signicantly inuences the biological activity of bio-
pharmaceutical proteins49,50 and potentiates binding of cell
surface receptors.51,52 Controlling the frequency, efficiency, and
site specicity of sialylated determinants may thus create advan-
tageous binding opportunities for the targets and/or therapeutics.Conclusions
In addition to the multiplicity of occupied sites on a given glyco-
protein, the number of glycoforms that exist within a single site
adds sufficient challenge to glycoconjugate characterization and
manufacturing. Herein we used metabolic incorporation of
unnatural sialic acids as a method for installing a unique mass
label on cell surfaces to investigate the tendency of sialylation.
This technique allowed for extensive characterization of
membrane-associated glycoproteins and glycolipids, revealing
cellular, structural, and spatial preferences for sialic acid expres-
sion. The methods presented here can probe structural diversity
and be applied towards the design of therapeutics, including
those to block or accentuate binding of key glycan–protein inter-
actions that mediate cellular homeostasis, cancer, and immunity.Experimental
Cell culture
Caco-2 intestinal epithelial cells were obtained from the
American Type Culture Collection (ATCC, VA) and grown 14
days post-conuence in Eagle's Minimum Essential Medium
(EMEM) supplemented with non-essential amino acids, 1 g L1
D-glucose, 2 mM L-glutamine, 10% (v/v) fetal bovine serum, and
100 U mL1 penicillin and streptomycin. KKU-213 and KKU-
213L5 cholangiocarcinoma cells were obtained from the Japa-
nese Collection of Research Bioresources Cell Bank (JCRB,
Osaka, Japan) and grown in Ham's F12 medium supplemented
with non-essential amino acids, 1.8 g L1 D-glucose, 1 mM
L-glutamine, 10% (v/v) fetal bovine serum, and 100 U mL1
penicillin and streptomycin. PNT2 prostate epithelial cells were
grown in RPMI-1640 medium supplemented with non-essential
amino acids, 2 g L1 D-glucose, 2 mM L-glutamine, 10% (v/v)
fetal bovine serum, and 100 U mL1 penicillin and strepto-
mycin. HT-29 colorectal epithelial cells were obtained from
ATCC and grown 7 days post-conuence in McCoy's 5A medium
supplemented with non-essential amino acids, 3 g L1
D-glucose, 1.5 mM L-glutamine, 10% (v/v) fetal bovine serum,
and 100 U mL1 penicillin and streptomycin. All cells were
maintained at 37 C with 5% CO2 in a humidied incubator.Metabolic labeling of sialic acid-containing glycans
Metabolic labeling of cells has been described previously.15,53,54
In brief, per-O-acetylated azido N-acetylmannosamine (Man-
NAz) (Invitrogen, CA) was solubilized in dimethyl sulfoxide
(DMSO) at 100X and added to the growing media (nalChem. Sci., 2018, 9, 6271–6285 | 6281
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View Article Onlineconcentration of DMSO <0.1%). Cells were incubated at 37 C
with 5% CO2 for an additional 72 h, washed three times with
PBS, and harvested by scraping.
Cell membrane extraction
Details of the isolation of the cell membrane fraction have been
described previously.55 Briey, harvested cell pellets were
resuspended in homogenization buffer containing 0.25 M
sucrose, 20 mM HEPES-KOH (pH 7.4), and a 1 : 100 protease
inhibitor cocktail (EMD Millipore, CA). Cells were lysed on ice
using a probe sonicator (Qsonica, CT) operated with alternating
on and off pulses of 5 and 10 s, respectively. Lysates were pel-
leted by centrifugation at 2000  g for 10 min to remove the
nuclear fraction and unlysed cells. The supernatant was trans-
ferred to high speed tubes (Beckman Coulter, CA), loaded onto
a Beckman Optima TLX Ultracentrifuge at 4 C, and centrifuged
at 200 000  g for 45 min in series to remove other non-
membrane subcellular fractions. The resulting membrane
pellet was stored at 20 C until further processing.
Real-time PCR analysis
Quantitative real-time PCR was performed as described previ-
ously.55,56 Cells were harvested by scraping, washed twice with
PBS, and resuspended in RNAlater (Life Technologies, CA).
Total RNA was extracted using an RNeasy plus mini kit (Qiagen,
CA) and the quantity and quality of RNA were determined by
using a Qubit Fluorometer (Life Technologies) and TapeStation
2200 (Agilent Technologies, CA) following the manufacturer's
protocol. Total RNA was reverse transcribed to cDNA using the
iScript Reverse Transcription Supermix (Bio-Rad Laboratories,
CA) following the manufacturer's instructions. Predesigned
human glycosylation PrimePCR plates (Bio-Rad Laboratories)
were used for real-time PCR using the CFX96 Touch Real-Time
PCR detection system (Bio-Rad Laboratories). Analysis was
performed using CFX Manager 3.1 soware (Bio-Rad Labora-
tories). Gene expression was normalized to reference genes
GAPDH, TBP, and HPRT1.
Preparation of N-glycans
Proteins were suspended with 100 mL of 100 mM NH4HCO3 in
5 mM dithiothreitol and heated at 100 C for 10 s to thermally
denature the proteins. To release the glycans, 2 mL of peptide N-
glycosidase F (New England Biolabs, MA) were added to the
samples, which were then incubated in a microwave reactor
(CEM Corporation, NC) at 20 watts for 10 min. Aer addition of
400 mL of cold ethanol, samples were incubated at 80 C for
1.5 h to precipitate deglycosylated proteins and centrifuged at
21 000  g for 20 min. The precipitated proteins were dried and
stored at 20 C for O-glycan preparation and analysis. The
supernatant containing N-glycans was collected and dried. The
released N-glycans were puried by solid-phase extraction using
porous graphitized carbon (PGC) packed cartridges (Grace, IL).
The cartridges were rst equilibrated with nanopure water and
a solution of 80% (v/v) acetonitrile and 0.05% (v/v) triuoro-
acetic acid in water. The dried samples were solubilized, loaded
onto the cartridge, and washed with nanopure water at a ow6282 | Chem. Sci., 2018, 9, 6271–6285rate of 1 mL min1 to remove salts and buffer. N-Glycans were
eluted with a solution of 40% (v/v) acetonitrile and 0.05% (v/v)
triuoroacetic acid in water and dried prior to mass spectro-
metric analysis.
Preparation of O-glycans
Dried de-N-glycosylated proteins were suspended in 90 mL of
nanopure water and sonicated for 20 min. Subsequently, 10 mL
of 2 M NaOH and 100 mL of 2 M NaBH4 were added and mixed.
The mixture was incubated at 45 C for 18 h before cold 10%
acetic acid was added slowly on ice to adjust the pH to 5–7. Aer
centrifugation at 21 000  g for 20 min, the supernatant con-
taining free O-glycans was desalted using PGC cartridges as
described above. The eluted O-glycans were dried and further
puried using iSPE®-HILIC cartridges (Nest Group, MA). The
cartridges were conditioned with acetonitrile, 0.1% (v/v) tri-
uoroacetic acid in water, and 89% (v/v) acetonitrile with 1%
(v/v) triuoroacetic acid in water. The dried samples were
solubilized and loaded onto the column. The ow-through was
collected and reloaded two times. The column was then washed
with 89% (v/v) acetonitrile with 1% (v/v) triuoroacetic acid
in water. Puried O-glycans were eluted with a solution of 0.1%
(v/v) triuoroacetic acid in water and dried prior to mass spec-
trometric analysis.
Glycomic LC-MS/MS analysis
Glycan samples were reconstituted in nanopure water and
analyzed using an Agilent nano-LC/ESI QTOF MS system (Agi-
lent Technologies, CA). The samples were introduced into the
MS with a microuidic chip, which consists of a 40 nL enrich-
ment and 43  0.075 mm ID analytical columns packed with
porous graphitized carbon and a nanoelectrospray tip. Separa-
tion was carried out at a constant ow rate of 0.4 mL min1: (A)
3% (v/v) acetonitrile and 0.1% (v/v) formic acid in water and (B)
90% (v/v) acetonitrile in 1% (v/v) formic acid in water. MS
spectra were acquired at 1.5 s per spectrum over a mass range of
m/z 500–2000 in positive ionization mode. Mass inaccuracies
were corrected with reference m/z 1221.991.
Collision-induced fragmentation was performed with
nitrogen gas using a series of collision energies (Vcollision)
dependent on the m/z values of the N-glycans, based on the
equation Vcollision ¼ m/z (1.8/100 Da) V–2.4 V.
Glycomic data analysis
N-Glycan compositions were identied according to accurate
mass using an in-house retrosynthetic library constructed based
on the knowledge of the mammalian N-glycan biosynthetic
pathway.57 SiaNAz-labeled glycans were identied by the pres-
ence of fragment ions m/z 315.09 [SiaNAz  H2O + H]+ and m/z
333.10 [SiaNAz + H]+. Amino sialic acid (SiaNAm)-containing
O-glycans resulting from the reduction of SiaNAz were identi-
ed by the presence of fragment ions m/z 289.10 [SiaNAm 
H2O + H]
+ andm/z 307.11 [SiaNAm + H]+. Signals above a signal-
to-noise ratio of 5.0 were ltered and deconvoluted using
MassHunter Qualitative Analysis B.06.01 (Agilent, CA). Decon-
voluted masses were compared to theoretical masses usingThis journal is © The Royal Society of Chemistry 2018
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View Article Onlinea mass tolerance of 20 ppm and a false discovery rate of 0.6%.
Relative abundances were determined by integrating peak areas
for observed glycan masses and normalizing to the summed
peak areas of all glycans detected.
Preparation of glycopeptides
Proteins were denatured in 8 M urea at 55 C, reduced with
18 mM dithiothreitol, alkylated with 27 mM iodoacetamide,
diluted to 1 M urea with 50 mM ammonium bicarbonate, and
incubated with 1 mg trypsin at 37 C overnight. The resulting
peptides were concentrated in vacuo. Glycopeptides were
enriched by solid-phase extraction using ZIC-HILIC or iSPE®-
HILIC cartridges (Nest Group, MA). Cartridges were conditioned
with acetonitrile, 0.1% (v/v) triuoroacetic acid in water, fol-
lowed by 1% (v/v) triuoroacetic acid and 80% (v/v) acetonitrile
in water. Peptides were loaded onto the column (3) and
washed with 1% (v/v) triuoroacetic acid and 80% (v/v) aceto-
nitrile in water. The enriched products were eluted with a solu-
tion of 0.1% (v/v) triuoroacetic acid in water and dried prior to
mass spectrometric analysis.
Glycoproteomic LC-MS/MS analysis
Samples were loaded using 2% (v/v) acetonitrile and 0.1% (v/v)
triuoroacetic acid in water and separated using a reverse-phase
MichromMagic C18AQ column (200 mm, 150 mm) coupled with
a Q Exactive Plus Orbitrap mass spectrometer through a Prox-
eon nano-spray source (Thermo Scientic, CA). A binary
gradient was applied using 0.1% (v/v) formic acid in (A) water
and (B) acetonitrile: 0–75 min, 5–35% (B); 75–82 min, 35–80%
(B); 82–84 min, 80% (B); 84–85 min, 80–5% (B). Per acquisition,
the instrument was run in data-dependent mode as follows:
spray voltage, 2.2 kV; ion transfer capillary temperature, 200 C;
full scan mass range, m/z 700–2000; MS automatic gain control,
1  106; MS maximum injection time, 30 ms; MS/MS automatic
gain control, 5  104; MS/MS maximum injection time, 50 ms;
dynamic exclusion, 10 s; precursor resolution, 70 000; product
ion resolution, 17 500; precursor ion isolation width, 1.6 m/z;
stepped normalized collision energy, 17, 27, 37.
Glycoproteomic data analysis
Raw data were exported using xCalibur version 2.0 (Thermo
Scientic, CA). Proteins were identied using Byonic version
2.7.4 (Protein Metrics, CA) against the reviewed Swiss-Prot
human protein database with sample-specic parameters as
determined from Preview (Protein Metrics, CA): mass tolerances
of 5–10 ppm for the precursor and 10–20 ppm for fragment ions;
carbamidomethylation of cysteine as a xed modication;
oxidation of methionine and proline, deamidation of aspara-
gine and glutamine, methylation of lysine and arginine, and
acetylation of the protein N-terminus as variable modications;
N-glycosylation of asparagine (in-house human database or
custom list derived from released glycans); two missed cleavage
sites. Identications were ltered with a 1% false discovery rate
(FDR) and were accepted if the following conditions were met:
|log prob| >2; delta mod >10; byonic score >200. SiaNAz-labeled
peptides were identied using a SiaNAzylated N-glycan databaseThis journal is © The Royal Society of Chemistry 2018(383 entries, multiple Sia and SiaNAz combinations allowed)
and validated by the presence of fragment ions m/z 315.09
[SiaNAz  H2O + H]+ and m/z 333.10 [SiaNAz + H]+. The
secondary structure of glycosylated sites was predicted by Net-
SurfP version 1.1.58 Functional annotation analysis was per-
formed using the PANTHER database.59 Grand average of
hydropathicity (GRAVY) values were calculated from the
hydropathy values of each amino acid residue in the sequence.60
Amino acid frequency plots were generated using WebLogo
version 2.8.2.61 Glycopeptide fragmentation patterns were
annotated using Byonic or pGlyco.62 Individual protein abun-
dances were normalized to the total intensity of membrane
proteins using Byonic. Statistical analysis was performed using
a two-tailed Student's t-test.
Site-specic quantitation was performed using the area
under the curve. All abundances were normalized to the
maximal of each component as follows: the abundance of each
site within a protein was normalized to the most abundant
occupied site on the protein; the abundance of each glycoform
within a site was normalized to the abundances of the most
abundant glycoform observed on the given site.Glycosphingolipid extraction
Glycosphingolipid extraction was performed with modica-
tions from previous reports.63 To each prepared membrane
fraction of untreated and ManNAz-treated Caco-2 and PNT2
cells, a 500 mL solution of water : methanol : chloroform
(3 : 8 : 4) was added. Samples were vortexed and centrifuged at
21 000  g for 1 min. The supernatant was collected into
a separate vial. The extraction solution was added to the
remaining precipitate and the procedure repeated. Superna-
tants from the rst and second extractions were combined. To
facilitate phase separation, 100 mL of 1 M KCl was added to the
solution. The upper layer was collected and dried in vacuo.
GSLs were then puried by solid-phase extraction using C8
cartridges (Supelco, PA) and concentrated in vacuo prior to
mass spectrometric analysis.Glycolipidomic LC-MS/MS analysis
Puried glycosphingolipid samples were reconstituted in
methanol : water (1 : 1, v/v) and analyzed using an Agilent nano-
LC/ESI QTOF MS system (Agilent, CA). Samples were loaded
onto the enrichment column packed with ZORBAX C18 (5 mm)
at 3 mL min1. Separation was carried out on the analytical
column at a constant ow rate of 0.3 mL min1 using a binary
gradient as follows: (A) 20 mM ammonium acetate and 0.1%
(v/v) acetic acid in water; (B) 20 mM ammonium acetate and
0.1% (v/v) acetic acid in methanol : isopropanol (85 : 15, v/v);
70–75% (B), 0–1 min; 75–85% (B), 1–4 min; 85–100% (B), 4–40
min; 100% (B), 40–55 min; 100–70% (B), 55–58 min; 70% (B),
58–60 min. Per acquisition, one MS scan was followed by ve
MS/MS scans in data-dependent mode. Collision-induced
dissociation was performed using a series of collision energies
based on optimized conditions according to the formula
Vcollision ¼ m/z (1.2/100 Da) + 12.Chem. Sci., 2018, 9, 6271–6285 | 6283
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View Article OnlineGlycolipidomic data analysis
Data analysis was done with MassHunter Qualitative Analysis
B.07 and Pronder B.08 (Agilent, CA). GSL compounds were
identied with the nd by molecular feature function, and
ltered through an in-house library of GSL compositions. The
glycan and lipid composition of the GSLs was further conrmed
through tandem MS fragmentation spectra. A library that
includes the chemical formulas and retention times of identi-
ed GSLs was composed from the data exported from Mass-
Hunter. This library was then used in Pronder to perform
batch targeted feature extraction and to quantitate the peak
areas of the identied GSL compounds. The program included
both proton and ammonium adducts in its integration of
compound signals. A mass tolerance of 10 ppm was applied for
signal extraction. Peak smoothing using a Gaussian function
was applied prior to integration.Data accessibility
RawMS data and annotated MS/MS spectra have been uploaded
to the MASSIVE repository under access ID MSV000082036.Conflicts of interest
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